The invention comprises compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions containing the compounds or prodrugs of the compounds. The invention also comprises animal models and methods of making the animal models for studying diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc, and treatment of such diseases and disorders. The invention also comprises methods of treating such diseases and disorders. The invention also comprises methods of making the compounds, and methods of making selective glycosidase inhibitors.
本发明涉及用于选择性抑制糖苷酶的化合物,这些化合物的前药,以及含有这些化合物或其前药的制药组合物。本发明还涉及动物模型和制备这些动物模型的方法,用于研究与O-GlcNA
酰化酶缺乏或过度表达、O-GlcNAc的积累或缺乏以及这些疾病和障碍的治疗有关的疾病和障碍。本发明还涉及治疗此类疾病和障碍的方法。本发明还涉及制备这些化合物的方法,以及制备选择性糖苷酶
抑制剂的方法。